PDF (2177K)
摘要
目的 本研究基于全国范围内的大样本调查,旨在系统分析我国医疗机构血小板临床应用现状,深入探讨使用合理性及输注疗效管理中存在的主要问题,为构建规范化、精细化的血小板管理体系提供实证依据。方法 通过线上问卷调研法,面向全国医疗机构输血科人员发放自行设计的调查问卷,收集并分析血小板临床使用现状。结果 本次调查共回收答卷 2 268 份,最终有效问卷 1 375 份,来自全国 33 个省、自治区、直辖市(含港台)。 调查显示:血小板临床用量分布不均,67. 05%的机构年用量低于 500 单位,高需求集中于少数大型医院,且用量与医院等级、床位数的关联较弱。 疾病谱高度集中,血液系统疾病为最主要适应证(1 022 家),其次为创伤/ 手术和实体肿瘤。 在管理实践方面,70. 3%的机构常规开展输注后疗效评价,但存在评价深度不足(仅 58. 3%详细记录) 与机制缺位(12. 9%未建立)问题,主因为认知不足与标准缺失。 不良反应管理流程建设率(70. 0%)与上报普及率(91. 8%)较高,但存在执行不规范(仅 41. 9%规范执行)、分析不系统(仅 26. 4%常规开展)及反馈闭环缺失(56. 3%未向采供血机构反馈)等短板。 超九成机构自评使用合理性达 75%以上,但不合理使用的主要原因为“临床指征评估偏差” 与“供需时效性差异导致的过度预防性输注”。 血小板供应情况与疗效评价常规开展及使用合理性自评无显著统计学关联。 此外,血小板管理面临“短缺” 与“浪费” 并存困境:制剂质量总体可靠,但“ 超过有效期” 是报废首要原因(24. 80%);“供应不足、不及时”(79. 3%)与“保存期短”(46. 0%)被视作核心系统挑战。结论 我国血小板临床管理呈现出“制度广泛覆盖”与“闭环效能不足”并存的局面。 研究发现:首先,血小板消耗高度集中,但“供应紧张”与“过期报废”现象并存,揭示了库存动态调配与全流程管理能力的不足。 其次,临床对使用合理性虽普遍自信,但决策显著受限于供需时效性矛盾,存在资源约束下的“情境性妥协”。 最后,疗效评价与不良反应管理的流程框架虽已建立,却普遍存在记录不规范、分析不系统、跨机构反馈中断等问题,阻碍了管理效能从“形式” 向“实效” 的转化。 未来改进需系统推进:在临床层面,应强化指征培训、普及并统一疗效评估标准;在管理层面,须构建智能库存体系以优化供需匹配,并强制完善从不良反应分析到采供血机构反馈的闭环;在系统层面,应着力探索延长保存期等关键技术,以构建更具韧性、高效的血小板保障体系。
Abstract
Objective To systematically investigate the current status of platelet clinical application in Chinese medical institutions based on a nationwide large-sample survey, to analyze the key issues in rational utilization and transfusion efficacy management, and to provide empirical evidence for the construction of a standardized and refined platelet management system. Methods A selfdesigned online questionnaires was distributed to transfusion department personnel across China to collect and analyze the current clinical application status of platelets. Results A total of 2 268 questionnaires were collected in this survey, among which 1 375 valid responses were obtained from medical institutions across 33 provinces, autonomous regions, and municipalities directly under the Central Government (including Hong Kong, Macao and Taiwan). The survey revealed an uneven distribution of clinical platelet consumption; 67. 05% of facilities used fewer than 500 platelet units annually, and highvolume demand concentrated in a small number of largescale hospitals. Platelet consumption showed a weak correlation with hospital grade and hospital bed number. The disease spectrum for platelet transfusion was highly concentrated. Hematological diseases constituted the leading indication (reported by 1 022 institutions), followed by traumarelated surgeries and solid tumors. In terms of management practice, 70. 3% of participating institutions routinely performed posttransfusion efficacy evaluation. Nevertheless, this practice was limited by inadequate evaluation depth (only 58. 3% kept detailed records) and institutional deficiency (12. 9% had no relevant evaluation systems), mainly due to insufficient awareness and lack of unified criteria. Although 70. 0% of hospitals had established adversereaction management workflows and 91. 8% achieved highcoverage adverseevent reporting, prominent drawbacks remained, including nonstandardized implementation (standard practice was adopted merely in 41. 9% of centers), unsystematic outcome analysis (regular analysis performed in only 26. 4% of institutions), and broken feedback loops (56. 3% failed to send feedback to blood collection and supply institutions). More than 90% of hospitals selfrated their rational plateletuse rate above 75%. The primary contributors to inappropriate platelet transfusion included biased assessment of clinical indications and excessive prophylactic transfusion triggered by timerelated imbalance between blood supply and clinical demand. Platelet supply status had no statistically significant correlation with routine posttransfusion assessment and selfevaluated rational use levels. Furthermore, plateletrelated management was confronted with a paradox coexisting of supply shortage and bloodproduct waste. While platelet preparation quality was generally reliable, expiration was the top cause of platelet discard (24. 80%). Insufficient and untimely supply (79. 3%) and short shelflife (46. 0%) were recognized as core systematic challenges. Conclusion China’s current platelet management system features extensive institutional coverage paired with insufficient closedloop effectiveness. First, platelet consumption is highly concentrated, yet supply shortage and expiredproduct discard coexist, reflecting insufficient capacity for dynamic inventory allocation and wholeprocess administration. Second, clinicians generally hold positive selfevaluations for rational platelet application, whereas their clinical decisions are substantially constrained by conflicts between supply and demand, bringing about situational compromises under resource limitations. Third, despite established frameworks for efficacy evaluation and adverseevent management, widespread problems such as irregular documentation, unsystematic data analysis and interrupted crosshospital feedback hinder the transition from formal rules to practical management benefits.comprehensive strategies should be adopted for future improvement. Clinically, standardized training on transfusion indications and unified criteria for posttransfusion assessment should be popularized. Administratively, intelligent inventory systems ought to be constructed to balancedemand matching, and closedloop management covering adverseevent analysis and feedback to bloodsupply agencies should be enforced. At the systematic level, advances in technologies for prolonged platelet storage are urgently required to build a resilient and highefficiency plateletguarantee system.
关键词
Key words
[Author(id=1329502146111030081, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=929054001@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502146169750339, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146111030081, language=EN, stringName=Xuan WU, firstName=Xuan, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502146215887684, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146111030081, language=CN, stringName=吴璇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军总医院第一医学中心 输血医学科,北京 100853, bio={"content":"吴璇(1988-),女,技师,Email:929054001@qq.com
"}, bioImg=null, bioContent=吴璇(1988-),女,技师,Email:929054001@qq.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146035532605, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, xref=null, ext=[AuthorCompanyExt(id=1329502146048115518, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China), AuthorCompanyExt(id=1329502146064892735, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军总医院第一医学中心 输血医学科,北京 100853)])]), Author(id=1329502146257830726, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502146312356680, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146257830726, language=EN, stringName=Ting ZHANG, firstName=Ting, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502146358494025, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146257830726, language=CN, stringName=张婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军总医院第一医学中心 输血医学科,北京 100853, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146035532605, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, xref=null, ext=[AuthorCompanyExt(id=1329502146048115518, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China), AuthorCompanyExt(id=1329502146064892735, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军总医院第一医学中心 输血医学科,北京 100853)])]), Author(id=1329502146404631371, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502146463351629, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146404631371, language=EN, stringName=Xiaozhen GUAN, firstName=Xiaozhen, middleName=null, lastName=GUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502146509488974, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146404631371, language=CN, stringName=关晓珍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军总医院第一医学中心 输血医学科,北京 100853, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146035532605, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, xref=null, ext=[AuthorCompanyExt(id=1329502146048115518, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China), AuthorCompanyExt(id=1329502146064892735, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军总医院第一医学中心 输血医学科,北京 100853)])]), Author(id=1329502146555626320, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yuyangpla301@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502146614346578, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146555626320, language=EN, stringName=Yang YU, firstName=Yang, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502146656289619, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, authorId=1329502146555626320, language=CN, stringName=于洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军总医院第一医学中心 输血医学科,北京 100853, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146035532605, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, xref=null, ext=[AuthorCompanyExt(id=1329502146048115518, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China), AuthorCompanyExt(id=1329502146064892735, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910133174840, companyId=1329502146035532605, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军总医院第一医学中心 输血医学科,北京 100853)])])]
吴璇,张婷,关晓珍,于洋.
血小板临床使用合理性、输注疗效及不良反应管理的调查研究[J].
中国输血杂志, 2026, 39(7): 895-902 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.012
| [1] |
朱海斌. 供需不确定下考虑调剂的血小板库存管理研究[D]. 西南交通大学,2022.
|
| [2] |
ZHU H B. Platelet inventory management considering transshipment under uncertainty of supply and demand[D]. Southwest Jiaotong Univ,2022.
|
| [3] |
李沁洪,马祖军,黄攀. 随机需求和产出下血小板供应链库存协同控制[J].工业工程与管理, 2022, 27 (2): 136-145.
|
| [4] |
LI Q H, MA Z J, HANG P. Collaborative inventory control in a platelet supply chain with stochastic demand and yield[J].Ind Eng Manage, 2022, 27 (2) :136-145.
|
| [5] |
赖锦杨,叶女,梁艳芳,等. 广州市增城区手工分离浓缩血小板的供应及应用[J].中国卫生标准管理, 2022, 13 (19): 176-179.
|
| [6] |
LAI J Y, YE N, LIANG Y F, et al. Supply and application of manually condensed platelet in zengcheng district Guangzhou[J].Chin Health Stand Manag, 2022, 13 (19) :176-179.
|
| [7] |
伍彩发,吴均英,高炳谏. 云浮市献血者对献机采血小板的认知及意愿调查[J].中国医药科学, 2020, 10 (4): 11-16.
|
| [8] |
WU C F, WU J Y, GAO B J. Survey on awareness and willingness of machine-collected platelet of blood donors in Yunfu[J].China Med. Pharm, 2020, 10 (4) :11-16.
|
| [9] |
华敏玉,丁月平,王振兴,等. 新冠疫情对我国地市级血站单采血小板采集供应的影响[J].临床输血与检验, 2023, 25 (5): 641-648.
|
| [10] |
HUA M Y, DING Y P, WANG Z X, et al. Impacts of the COVID19 Pandemic on Apheresis Platelet Collection and Supply in PrefectureLevel Blood Stations across China[J].J Clin Transfus Lab Med,2023,25(5) :641-648.
|
| [11] |
华敏玉,牛伟,姚建,等. 国内 24 家地市级血站血小板成分血制备效率的研究[J].中国输血杂志, 2022, 35 (9): 937-942.
|
| [12] |
HUA M Y, NIU W, YAO J, et al. Study on the production efficiency of platelet components in 24 prefecture-level blood stations in China[J].Chin J Blood Transfusion, 2022, 35 (9) :937-942.
|
| [13] |
曹鸿霖,张胜,陈天成,等. 单采血小板报废的主要原因及预防措施[J].广东医科大学学报, 2022, 40 (3): 339-341.
|
| [14] |
CAO H L, ZHANG S, CHEN T C, et al. Main causes and preventive measures of platelet apheresis scrapping[J].J Guangdong Med Univ, 2022, 40 (3) :339-341.
|
| [15] |
孙琼芝. 2018-2022 年无锡市血小板采集和供应情况分析[J].中国医药指南, 2024, 22 (2): 125-129.
|
| [16] |
SUN Q Z. Analysis of platelet collection and supply in Wuxi City from 2018 to 2022[J].Guide China Med, 2024, 22 (2) :125-129.
|
| [17] |
FARIA GN, ZILOTTI LT, ANDRADE RJ. The most common inadequacies in red blood cell requests at a reference center in Western Paraná state[J].Hematol Transfus Cell Ther, 2023,45(2):165-169.
|
| [18] |
HUMBRECHT C, KIENTZ D, GACHET C. Platelet transfusion: Current challenges[J].Transfus Clin Biol, 2018,25(3):151-164.
|
| [19] |
苏日古嘎,珠丽,马敬. .肿瘤患者血小板输注效果的影响因素分析[J]. 中国社区医师, 2025,41(3): 42-44.
|
| [20] |
SU R G G, ZHU L, MA J. .Analysis of influencing factors of platelet transfusion efficacy in patients with malignant tumors[J]. Chinese Community Doctors, 2025,41(3): 42-44.
|
| [21] |
龚道方,龙海波,刘昭国,等. 临床 276 例次单采血小板输注效果及相关因素分析[J].临床输血与检验, 2018,20(4):365-368.
|
| [22] |
GONG D F, LONG H B, LIU Z G, et al. Analysis of apheresis platelet transfusion efficacy and related factors in 276 clinical transfusion episodes[J].J Clin Transfus Lab Med, 2018,20(4):365-368.
|
| [23] |
李至,段雨函. 急性髓系白血病患者血小板输注疗效的影响因素分析及预测模型构建[J].国际检验医学杂志,2026,47(3):273-278.
|
| [24] |
LI Z, DUAN Y H. Analysis of influencing factors and construction of prediction model for platelet transfusion efficacy in patients with acute myeloid leukemia[J].Int J Lab Med, 2026,47(3):273-278.
|
| [25] |
于洋,罗圆圆. 血小板制剂细菌污染监测与控制:国际实践与中国本土化路径探索[J].中华医院感染学杂志,2025,35(19):2881-2886. YU Y,
|
| [26] |
LUO Y Y. Monitoring and control of bacterial contamination in platelet preparations:international practices and exploration of localized strategies in China[J].Chin J Nosocomiol, 2025,35(19):2881-2886.
|
| [27] |
廖秀云,黄杨,张媛,等. 我国血小板细菌污染情况的 Meta 分析[J].中国输血杂志,2025,38 (9): 1272-1279.
|
| [28] |
LIAO X Y, HUANG Y, ZHANG Y, et al. Metaanalysis of bacterial contamination status of platelet preparations in China[J].Chin J Blood Transfusion, 2025,38(9): 1272-1279.
|
| [29] |
LEVY J H, NEAL M D, HERMAN J H. Bacterial contamination of platelets for transfusion:strategies for prevention[J].Crit Care,2018,22(1):271.
|
| [30] |
崔琳,刘晓卫,刘燕,等. 山东省血液中心血液成分制备和临床供血调查分析[J].山东医药,2019,59(23): 77-79.
|
| [31] |
CUI L, LIU X W, LIU Y, et al. Investigation and analysis on blood component preparation and clinical blood supply in Shandong blood center[J].Shandong Med J, 2019,59(23):77-79.
|
| [32] |
刘妍妍,李红珠,樊晶. 新冠疫情影响下天津地区无偿献血人群特征分析[J].中国输血杂志,2021,34(12): 1363-1367.
|
| [33] |
LIU Y Y, LI H Z, FAN J. Analysis on characteristics of voluntary blood donors in Tianjin area under the influence of COVID19 pandemic[J].Chin J Blood Transfusion,2021,34(12):1363-1367.
|
| [34] |
吴学敏,李小飞. 输血不良事件管理系统构建及应用[J].中国输血杂志,2023,36(11):1045-1049.
|
| [35] |
WU X M, LI X F. Construction and application of blood transfusion adverse event management system[J].Chin J Blood Transfusion, 2023,36(11):1045-1049.
|
| [36] |
SHOKOUHIFAR M, SABBAGHI M M, PILEVARI N. Inventory management in blood supply chain considering fuzzy supply/ demand uncertainties and lateral transshipment[J].Transfus Apher Sci,2021,60(3):103103.
|
| [37] |
周吉成,胡丽华,马现君,等. 创伤性出血患者血液管理专家共识(2022 年版)[J].中国临床新医学,2022, 15(6):469-476.
|
| [38] |
ZHOU J C, HU L H, MA X J, et al. Expert consensus on patient blood management for patients with traumatic hemorrhage (2022 Version)[J].Chin J New Clin Med, 2022,15(6):469-476.
|
| [39] |
王翠娥,孔长虹,徐烨彪,等. 浙江省血小板供受者基因型配合信息系统构建及应用[J].中国卫生质量管理,2022,29(11):91-93,98.
|
| [40] |
WANG C E, KONG C H, XU Y B, et al. Construction and application of platelet donor-recipient genotype matching information system in Zhejiang province[J].Chin J Health Qual Manag,2022,29(11):91-93+98.
|
| [41] |
钟丽红,吴泳彬,杨定坤,等. 血小板输注无效的原因及其配型疗效的相关研究[J].血栓与止血学,2018, 24(2):227-230.
|
| [42] |
ZHONG L H, WU Y B, YANG D K, et al. Study on causes of platelet refractoriness and curative effect of platelet matching[J].Chin J Thromb Hemost, 2018, 24 (2): 227-230.
|
| [43] |
郭峻峰. 血小板抗体检测在血小板输注无效的血液病患者中临床意义的研究[D]. 浙江中医药大学,2022.
|
| [44] |
GUO J F. Study on clinical significance of platelet antibody detection in hematological disease patients with platelet transfusion refractoriness[D]. Zhejiang Chinese Medical University,2022.
|
| [45] |
梁若鹄,黄彦,张颖,等. 单采血小板解聚困难原因分析及预防措施探究[J].齐齐哈尔医学院学报,2018, 39(1):38-39.
|
| [46] |
LIANG R H, HUANG Y, ZHANG Y, et al. Analysis of causes and exploration of preventive measures for difficult disaggregation of apheresis platelets[J].Journal of Qiqihar Medical University,2018,39(1):38-39.
|
| [47] |
王利华. 血站无偿献血中机采血小板造成冲红原因分析及影响因素研究[J].中国当代医药,2021,28(28): 72-74,78.
|
| [48] |
WANG L H. Analysis of causes and influencing factors of red cell contamination in apheresis platelets collected from voluntary blood donors at blood stations[J].China Mod Med,2021,28(28):72-74,78.
|
| [49] |
刘磊. 血小板保存技术的应用研究进展[J].解放军医药杂志,2020,32(8):108-111,116.
|
| [50] |
LIU L. Research progress on the application of platelet preservation technology[J].Med & Pharm J Chin PLA, 2020,32(8):108-111,116.
|